In brief, the results indicate that the rs684232 site and the target genes VPS53, FAM57A, and GEMIN4 are positively associated with prostate cancer cell malignancy, and the high expression for the three genes are associated with poor prognosis for cancer patients. This evidence concerns the gene VPS53 and Familial prostate cancer.